Saturday, July 11, 2026

pharma · Breast Cancer · Multiple Sclerosis (MS)

HOFFMANN-LA ROCHE

Hoffmann-La Roche is a pharma organization headquartered in Basel, CH. Primary therapeutic focus areas include Breast Cancer, Multiple Sclerosis (MS), Spinal Muscular Atrophy (SMA), Non-Small Cell Lung Cancer, Solid Tumo

Mississauga, Ontario L5N 5M8, CA HQ
10 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Mississauga, Ontario L5N 5M8, CA
Employees
10
Programs
286
Drugs
212
Patents
0
Clinical program

BP45801

Phase 1 · other · Healthy volunteers

BP45801 for Healthy volunteers is a Phase 1 program (other) at Hoffmann-La Roche with 1 ClinicalTrials.gov record(s).

Internal code BP45801

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Hoffmann-La Roche
Phase
Phase 1
Modality
other
Indication
Healthy volunteers
Status
active
Trials
1

Clinical trials